Skip to main content
SurgEase Research

Sitara Study

By September 3, 2020September 10th, 2020No Comments

Sitara Study


A feasibility study to assess a point-of-care endo-luminal diagnostic tool and tele-endoscopy platform in reducing time to histological confirmation of rectal cancer & providing remote diagnostic support from an international faculty (Sitara study)


Prospective, phase 1 feasibility study


To determine patient and clinician acceptability and diagnostic utility of a novel point of care digital rectoscopy device and its associated software platform in reducing time to histological confirmation of rectal cancer

Outcome measures
  • Time to histological diagnosis for rectal cancer
  • Clinician acceptability
  • Patient acceptability
  • Patient safety
  • Diagnostic accuracy
  • Diagnostic sensitivity and specificity for an ‘abnormal rectum’
  • Economic analysis of LumenEye

Adult patients presenting to secondary care services because of a change in bowel habit, rectal bleeding or assessment for symptoms suspicious of rectal cancer


Patients aged 18-74

Patients presenting to secondary care settings

With any of:

  1. Rectal bleeding
  2. Established rectal cancer
  3. Positive Faecal occult blood test / Faecal immunochemical test (FIT) or
  4. Faecal calprotectin
  5. Any symptom that would warrant referral on a cancer referral

6 Months



Host site

Tata Memorial Hospital, Mumbai
Imperial College
Kings Hospital

For further information about this study please contact

Get In Touch

Contact UsCareers

Get In Touch

Contact UsCareers